drugset / Trial / NCT03686787

Oral Tranexamic Acid and Laser for Treatment of Melasma

NCT03686787 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Tranexamic acid and 1927 diode laser non-ablative fractionated laser for the treatment of Melasma.

Timeline

Start
2018-10-01
Primary completion
2019-07-31
Completion
2019-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule — Oral